Publication:
Malignant tumors in hemodialysis patients

Simple item page
dc.contributor.authorČučković, Č. (16941762300)
dc.contributor.authorDjukanović, L. (59576779300)
dc.contributor.authorJanković, S. (7101906308)
dc.contributor.authorStanojcić, A. (6508111054)
dc.contributor.authorDragićević, P. (6602959043)
dc.contributor.authorRadmilović, A. (6603241533)
dc.contributor.authorLambić, L. (6507540377)
dc.contributor.authorStojánović, M. (7004959134)
dc.contributor.authorMilić, M. (57196937121)
dc.contributor.authorBaković, J. (16940702700)
dc.contributor.authorRadović, M. (7005330183)
dc.contributor.authorLabudović, M. (16942762700)
dc.date.accessioned2025-06-12T11:51:43Z
dc.date.available2025-06-12T11:51:43Z
dc.date.issued1996
dc.description.abstractWe reviewed the incidence of malignant tumors among 923 patients with chronic renal failure, treated with hemodialysis (HD) in seven dialysis centers in Serbia between January 1983 and July 1993. Neoplasms were diagnosed in 45 cases (4.9%). The mean age of the cancer patients was 58.7 years. Eighteen cases (40.0%) were diagnosed in the first year after starting HD treatment and 21 (46.7%) cases were detected less than 5 years after induction of HD treatment. Most of the cancer patients (60.0%), especially the patients with Balkan endemic nephropathy (31.1 %), developed cancer of the urinary tract. We concluded that HD patients have a several times greater risk of developing malignant tumors than the general population. © 1996 S. Karger AG, Basel.
dc.identifier.urihttps://doi.org/10.1159/000189167
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-9344268781&doi=10.1159%2f000189167&partnerID=40&md5=d1637b41bf502e05383a5260af7ce899
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/1569
dc.subjectChronic renal failure
dc.subjectHemodialysis
dc.subjectMalignant tumors
dc.titleMalignant tumors in hemodialysis patients
dspace.entity.typePublication

Files

Collections

Publikacije / Publications